Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Rysz

Showing results (141-150 of 330) with videos related to

Pageof 33
Sort By:
Current Vascular Pharmacology|October 25, 2016
Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) PatientsAnna Gluba-Brzozka, Beata Franczyk, Piotr Bartnicki, et al.
Expert Opinion on Pharmacotherapy|October 9, 2018
Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?Beata Franczyk, Anna Gluba-Brzózka, Łukasz Jurkiewicz, et al.
Nature Reviews. Nephrology|February 24, 2010
The role of Toll-like receptors in renal diseasesAnna Gluba, Maciej Banach, Simon Hannam, et al.
Current Pharmaceutical Design|January 3, 2013
Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevanceMaciej Banach, Malgorzata Malodobra-Mazur, Anna Gluba, et al.
Lipids in Health and Disease|February 11, 2014
Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot studyMariusz Stępień, Anna Stępień, Rafał N Wlazeł, et al.
Current Vascular Pharmacology|January 26, 2012
Acute coronary syndromes in patients with chronic kidney diseaseBeata Franczyk-Skóra, Anna Gluba, Maciej Banach, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 17, 2014
Assessment of the relationship between lipid parameters and obesity indices in non-diabetic obese patients: a preliminary reportAnna Stępień, Mariusz Stępień, Rafał N Wlazeł, et al.
Atherosclerosis|September 6, 2017
The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesisBożena Sosnowska, Mohsen Mazidi, Peter Penson, et al.
Current Vascular Pharmacology|October 16, 2008
The role of trimetazidine after acute myocardial infarctionMaciej Banach, Jacek Rysz, Aleksander Goch, et al.
BMC Nephrology|December 5, 2012
Prevention of sudden cardiac death in patients with chronic kidney diseaseBeata Franczyk-Skóra, Anna Gluba, Maciej Banach, et al.
Pageof 33

Showing results (141-150 of 330) with videos related to

Sort By:
Pageof 33
Current Vascular Pharmacology|October 25, 2016
Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) PatientsAnna Gluba-Brzozka, Beata Franczyk, Piotr Bartnicki, et al.
Expert Opinion on Pharmacotherapy|October 9, 2018
Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?Beata Franczyk, Anna Gluba-Brzózka, Łukasz Jurkiewicz, et al.
Nature Reviews. Nephrology|February 24, 2010
The role of Toll-like receptors in renal diseasesAnna Gluba, Maciej Banach, Simon Hannam, et al.
Current Pharmaceutical Design|January 3, 2013
Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevanceMaciej Banach, Malgorzata Malodobra-Mazur, Anna Gluba, et al.
Lipids in Health and Disease|February 11, 2014
Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot studyMariusz Stępień, Anna Stępień, Rafał N Wlazeł, et al.
Current Vascular Pharmacology|January 26, 2012
Acute coronary syndromes in patients with chronic kidney diseaseBeata Franczyk-Skóra, Anna Gluba, Maciej Banach, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 17, 2014
Assessment of the relationship between lipid parameters and obesity indices in non-diabetic obese patients: a preliminary reportAnna Stępień, Mariusz Stępień, Rafał N Wlazeł, et al.
Atherosclerosis|September 6, 2017
The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesisBożena Sosnowska, Mohsen Mazidi, Peter Penson, et al.
Current Vascular Pharmacology|October 16, 2008
The role of trimetazidine after acute myocardial infarctionMaciej Banach, Jacek Rysz, Aleksander Goch, et al.
BMC Nephrology|December 5, 2012
Prevention of sudden cardiac death in patients with chronic kidney diseaseBeata Franczyk-Skóra, Anna Gluba, Maciej Banach, et al.
Pageof 33